AI-generated summary
The authors report a randomized trial of 155 children receiving high-dose methotrexate, comparing intraoral and extraoral red light therapy for preventing oral mucositis. They found no significant difference in mucositis occurrence (41.1% intraoral versus 30.5% extraoral) or severity, while extraoral treatment took about 30 seconds per session compared with about 6 minutes intraorally.
- Participants
- 155
- Who or what was studied
- Pediatric oncology patients aged 1 to 18 years receiving high-dose methotrexate for leukemia, lymphoma, or osteosarcoma
- Wavelengths
- 660 nm
- Limits stated in the abstract
- The abstract describes a single-blind design and does not report a placebo or sham control group, and it does not state a power calculation or follow-up beyond day 10.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on link.springer.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 660 nm
- Power
- 100 mW
- Total energy
- 1 J
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation, Dose, Oral mucositis, Randomized controlled trial, Dosimetry. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.